Detroit City Council has approved a $12.69M opioid settlement against four companies, with most of the money allocated to fund opioid abatement and prevention strategies reported by The Center Square.
Settlement Details and National Agreement
The $12.69M opioid settlement is against four companies that contributed to the opioid epidemic in Detroit, with most of the money allocated to fund opioid abatement and prevention strategies.
The opioid epidemic has caused 2,000 deaths in Detroit, and the settlement aims to fund opioid abatement and prevention strategies. It also requires companies to change how they handle opioids, such as compliance structures, pharmacist judgment, and suspicious order monitoring.
Allergan Finance, CVS Health Corp. and Walmart have agreed to a $13 billion opioid settlement, which aims to fund programs to reduce opioid abuse and addiction. The agreement includes banning the promotion and lobbying of opioids and changing how they handle opioids. This agreement is one of the largest settlements in the country’s history and is a significant step in curbing the opioid epidemic in Detroit reported by Metrotimes.
Detroit’s Opioid Crisis and Settlement Impact
The opioid epidemic has caused thousands of drug overdose deaths in Detroit, with 86% of those involving opioids. It has also cost the city an estimated $925 million annually, including healthcare, treatment, prevention programs, traffic crashes, and foster care.
The $12.69M opioid settlement approved by the Detroit City Council will help fund opioid abatement and prevention strategies in Detroit. It is part of a $13 billion national agreement, with most of the funds allocated to opioid abatement and prevention programs. Teva and Allergan have agreed to ban the promotion and lobbying of opioids, while CVS and Walmart have agreed to change their compliance structures.
Read Also: Florida Father Appears in Court Over Alleged Murder of Child’s Mother and 2-Year-Old Son